N6-methyladenosine regulates metabolic remodeling in kidney aging through transcriptional regulator GLIS1.

Li Xu, Shuo Chen, Qiuling Fan, Yonghong Zhu, Hang Mei, Jiao Wang, Hongyuan Yu, Ying Chen, Fan Liu

Department of Laboratory Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524003, China.Department of Laboratory Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524003, China. · pubmed

Paper

Abstract

Age-related kidney impairment, characterized by tubular epithelial cell senescence and renal fibrosis, poses a significant global public health threat. Although N6-methyladenosine (m6A) methylation is implicated in various pathological processes, its regulatory mechanism in kidney aging remains unclear.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the role of N6-methyladenosine methylation in kidney aging, focusing on its regulatory mechanisms which could contribute to understanding the biological processes underlying aging and age-related diseases. While it addresses a significant aspect of aging, the findings appear to be more of a solid research contribution rather than a groundbreaking discovery, thus warranting a moderate impact score.

Author of this paper? Send a correction.